@actpocket35
Active 1 year, 3 months ago
A randomized, double-blind, placebo-controlled phase 2 trial of the HPV16/18 vaccine encompassed healthy Chinese females, categorized into three age groups (9-17 years, 18-26 years, 27-45 years). These comprised 600, 240, and 360 participants, respectively, and were randomized to receive three doses of the vaccine or placebo, over a time frame […] View